{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:50Z","timestamp":1761059330489},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2490-12-10","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T23:40:30Z","timestamp":1335310830000},"source":"Crossref","is-referenced-by-count":4,"title":["Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan"],"prefix":"10.1186","volume":"12","author":[{"given":"Jamal","family":"Khader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Abuodeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelateif","family":"Almousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Farah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadwa","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"issue":"3","key":"206_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urolonc.2005.05.010","volume":"24","author":"I Alomary","year":"2006","unstructured":"Alomary I, Samant R, Gallant V: Treatment of stage I seminoma: a 15-year review. Urol Oncol. 2006, 24 (3): 180-183. 10.1016\/j.urolonc.2005.05.010.","journal-title":"Urol Oncol"},{"issue":"1","key":"206_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.critrevonc.2008.10.007","volume":"71","author":"D Pectasides","year":"2009","unstructured":"Pectasides D, Pectasides E, Constantinidou A, Aravantinos G: Stage I testicular seminoma: management and controversies. Crit Rev Oncol Hematol. 2009, 71 (1): 22-28. 10.1016\/j.critrevonc.2008.10.007.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"206_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.coc.0000255613.72254.31","volume":"30","author":"GY Yang","year":"2007","unstructured":"Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR: Long-term outcome of stage I seminoma. Am J Clin Oncol. 2007, 30 (2): 205-210. 10.1097\/01.coc.0000255613.72254.31.","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"206_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1442-2042.2010.02645.x","volume":"17","author":"T Kamba","year":"2010","unstructured":"Kamba T, Kamoto T, Okubo K, et al: Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients. Int J Urol. 2010, 17 (12): 980-987. 10.1111\/j.1442-2042.2010.02645.x.","journal-title":"Int J Urol"},{"issue":"3","key":"206_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jnci\/djq535","volume":"103","author":"P Chung","year":"2011","unstructured":"Chung P, Warde P: Stage I seminoma: adjuvant treatment is effective but is it necessary?. J Natl Cancer Inst. 2011, 103 (3): 194-196. 10.1093\/jnci\/djq535.","journal-title":"J Natl Cancer Inst"},{"key":"206_CR6","first-page":"199","volume-title":"TNM Classification of Malignant Tumours","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C: TNM Classification of Malignant Tumours. 2002, John Wiley & Sons, Hoboken, New Jersey, 199-202. 6","edition":"6"},{"issue":"4","key":"206_CR7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","volume":"17","author":"SD Foss\u00e5","year":"1999","unstructured":"Foss\u00e5 SD, Horwich A, Russell JM, et al: Optimal radiotherapy field size for stage I testicular seminoma: a Medical Research Council (UK) randomised trial. J Clin Oncol. 1999, 17 (4): 1146-1154.","journal-title":"J Clin Oncol"},{"key":"206_CR8","volume-title":"Jordan Cancer Registry: Cancer incidence in Jordan 2008","author":"M Tarawneh","year":"2008","unstructured":"Tarawneh M, Nimri O, Arqoub K, Zaghal M: Jordan Cancer Registry: Cancer incidence in Jordan 2008. 2008, Ministry of Health, Non-Communicable Diseases Directorate"},{"issue":"2","key":"206_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jso.2930330218","volume":"33","author":"NK Bissada","year":"1986","unstructured":"Bissada NK, el Senoussi M, Hanash KA, Hefty T, Morcos R: Testicular seminomas in Saudi Arabia: clinical characteristics, prognostic indicators, and recommendations for management. J Surg Oncol. 1986, 33 (2): 136-139. 10.1002\/jso.2930330218.","journal-title":"J Surg Oncol"},{"issue":"3","key":"206_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.hoc.2011.03.008","volume":"25","author":"G Mok","year":"2011","unstructured":"Mok G, Warde P: Management of stage I testicular seminoma. Hematol Oncol Clin North Am. 2011, 25 (3): 503-516. 10.1016\/j.hoc.2011.03.008. vii-iii","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 4","key":"206_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/annonc\/mdp138","volume":"20","author":"HJ Schmoll","year":"2009","unstructured":"Schmoll HJ, Jordan K, Huddart R, et al: Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009, 20 (Suppl 4): 83-88.","journal-title":"Ann Oncol"},{"issue":"6","key":"206_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00066-009-1958-z","volume":"185","author":"J Clasen","year":"2009","unstructured":"Clasen J, Schmidberger H, Souchon R, et al: What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: an analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients. Strahlenther Onkol. 2009, 185 (6): 349-354. 10.1007\/s00066-009-1958-z.","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"206_CR13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.ijrobp.2006.06.054","volume":"66","author":"M Niewald","year":"2006","unstructured":"Niewald M, Freyd J, Fleckenstein J, Wullich B, R\u00fcbe C: Low-dose radiotherapy for Stage I seminoma\u2013long-term results. Int J Radiat Oncol Biol Phys. 2006, 66 (4): 1112-1119. 10.1016\/j.ijrobp.2006.06.054.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"206_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","volume":"23","author":"WG Jones","year":"2005","unstructured":"Jones WG, Fossa SD, Mead GM, et al: A randomised trial of 30 Gy vs 20 Gy in the adjuvant treatment of stage I testicular seminoma (MRC TE18, EORTC 30942, ISRCTN18525328). J Clin Oncol. 2005, 23 (6): 1200-1208. 10.1200\/JCO.2005.08.003.","journal-title":"J Clin Oncol"},{"issue":"2","key":"206_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0360-3016(97)00733-5","volume":"40","author":"K Sultanem","year":"1998","unstructured":"Sultanem K, Souhami L, Benk V, et al: Para-aortic irradiation only appears to be adequate treatment for patients with Stage I seminoma of the testis. Int J Radiat Oncol Biol Phys. 1998, 40 (2): 455-459. 10.1016\/S0360-3016(97)00733-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"206_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1442-2042.2005.01114.x","volume":"12","author":"RE Power","year":"2005","unstructured":"Power RE, Kennedy J, Crown J, Fraser I, Thornhill JA: Pelvic recurrence in stage I seminoma: a new phenomenon that questions modern protocols for radiotherapy and follow-up. Int J Urol. 2005, 12 (4): 378-382. 10.1111\/j.1442-2042.2005.01114.x.","journal-title":"Int J Urol"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","volume":"89","author":"L Travis","year":"1997","unstructured":"Travis L, Curtis R, Storm H, et al: Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 1997, 89: 1429-1439. 10.1093\/jnci\/89.19.1429.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"206_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1096-9098(199801)67:1<38::AID-JSO8>3.0.CO;2-N","volume":"67","author":"ME Stein","year":"1998","unstructured":"Stein ME, Leviov M, Drumea K, et al: Radiation-induced tumors in irradiated stage I testicular seminoma: results of a 25-year follow-up (1968\u20131993). J Surg Oncol. 1998, 67 (1): 38-40. 10.1002\/(SICI)1096-9098(199801)67:1<38::AID-JSO8>3.0.CO;2-N.","journal-title":"J Surg Oncol"},{"issue":"9482","key":"206_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","volume":"366","author":"RTD Oliver","year":"2005","unstructured":"Oliver RTD, Mason MD, Mead GM, et al: for the MRC TE19 collaborators and the EORTC 30982 collaborators. Radiotherapy versus single dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005, 366 (9482): 293-300. 10.1016\/S0140-6736(05)66984-X.","journal-title":"Lancet"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002, 20: 4448-4452. 10.1200\/JCO.2002.01.038.","journal-title":"J Clin Oncol"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1470-2045(03)01278-6","volume":"4","author":"RH Jones","year":"2003","unstructured":"Jones RH, Vasey PA: Part I: testicular cancer-management of early disease. Lancet Oncol. 2003, 4: 730-736. 10.1016\/S1470-2045(03)01278-6.","journal-title":"Lancet Oncol"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1200\/JCO.2004.12.966","volume":"22","author":"A Horwich","year":"2004","unstructured":"Horwich A: Radiotherapy in stage I seminoma of testis. J Clin Oncol. 2004, 22: 585-588. 10.1200\/JCO.2004.12.966.","journal-title":"J Clin Oncol"},{"issue":"12","key":"206_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1159\/000096608","volume":"29","author":"J Martin","year":"2006","unstructured":"Martin J, Chung P, Warde P: Treatment options, prognostic factors and selection of treatment in stage I seminoma. Onkologie. 2006, 29 (12): 592-598. 10.1159\/000096608.","journal-title":"Onkologie"},{"issue":"6","key":"206_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000090493","volume":"69","author":"F Christoph","year":"2005","unstructured":"Christoph F, Weikert S, Miller K, Schrader M: New guidelines for clinical stage I testicular seminoma?. Oncology. 2005, 69 (6): 455-462. 10.1159\/000090493.","journal-title":"Oncology"},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0959-8049(00)00140-4","volume":"36","author":"R Francis","year":"2000","unstructured":"Francis R, Bower M, Brunstrom G, et al: Surveillance for stage I testicular germ cell tumors: results and cost benefit analysis of management options. Eur J Cancer. 2000, 36: 1925-1932. 10.1016\/S0959-8049(00)00140-4.","journal-title":"Eur J Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2490-12-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T15:14:08Z","timestamp":1594048448000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/1471-2490-12-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/1471-2490-12-10","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]},"article-number":"10"}}